From Chronic Back Pain to Black Diamond Runs: Dr. Jason M. Cuéllar Restores Motion with Three-Level Lumbar Disc Replacement for Endoscopic Spine Pioneer Dr. Scott Adelman

July 7, 2025 11:45 AM

When Dr. Scott Adelman, a nationally recognized leader in endoscopic spine surgery and interventional pain management, began experiencing debilitating low back pain, he understood better than most the complexities and limitations of traditional surgical options. For years, he pursued conservative treatments-physical therapy, spinal injections, and careful lifestyle modifications-but the pain continued to escalate, eventually preventing him from...

Read more

Venture Medical Leads Strategic Investment in Plasmacure to Advance Breakthrough Cold Plasma Technology for Chronic Wound Healing

July 7, 2025 11:00 AM

Venture Medical, LLC, a leader in advanced wound care solutions, today announced the closing of a strategic investment in Plasmacure B.V., the Dutch MedTech innovator behind PLASOMA, an award-winning cold plasma therapy for complex wound healing. Venture Medical is leading a €6 million Series A round alongside Coöperatie VGZ, Noaber, Stichting Triade, and existing investors EIC Fund and OostNL. In addition to the direct investment, Venture...

Read more

Desert Oasis Healthcare Celebrates 45 Years of Serving the Coachella Valley and High Desert

July 7, 2025 10:00 AM

Desert Oasis Healthcare (DOHC) is proud to celebrate 45 years of service, innovation, and commitment to the health and wellness of the Coachella Valley and High Desert.What began as one of the first medical groups in the region in 1981 has grown into a multidisciplinary network of compassionate providers and care teams serving more than 60,000 members. DOHC has continuously evolved to meet the changing needs of the community, integrating...

Read more

Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements

July 7, 2025 9:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) (the "Company"), a leader in PCR-based DNA technologies, today announced that on July 2, 2025, it received written notice (the "Compliance Notice") from The Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires that companies listed on the Nasdaq Capital Market maintain a minimum bid price of $1.00 per share, and that...

Read more

Medical Care Technologies (OTC: MDCE) Unveils Bold Vision for Mobile Self-Care Innovation

July 7, 2025 8:17 AM

Medical Care Technologies Inc. (OTC PINK:MDCE), a health technology company focused on AI-powered self-care and mobile diagnostics, is proud to announce the launch of its official website at www.medicalcaretechnologies.com. The new platform highlights the company's strategic mission to deliver transformative, AI-driven health solutions accessible via smartphone-bringing early detection and preventive medicine directly into the hands of users...

Read more

MediQuant Expands DataArk(R) Platform to Support Ambulatory Facilities with Launch of CommunityArk(TM)

July 7, 2025 8:00 AM

MediQuant, LLC, a leader in cloud-based data archiving and interoperability solutions for hospitals and health systems, today announced the launch of CommunityArk™, a new module of the company's flagship DataArk® product platform.CommunityArk offers small hospitals and ambulatory facilities a cost-effective, accelerated pathway to archive legacy Ambulatory Electronic Medical Records (AEMRs) and other applications while maintaining full access to...

Read more

Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence

July 7, 2025 8:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced its new direct-to-consumer (DTC) "I Wish I Knew" campaign for Xifaxan® (rifaximin), the first and only medicine FDA approved for the reduction in risk of overt hepatic encephalopathy (OHE) recurrence in adults. Designed to raise awareness about OHE and the role of Xifaxan, "I Wish I Knew" seeks to educate and...

Read more

Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape

July 7, 2025 8:00 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent detection, today announced a five-year distribution partnership with Solomon Technology Corporation, a leader in machine vision, industrial AI, and smart automation. The partnership aims to fast-track Ainos' AI Nose platform into Asia's key manufacturing sectors: semiconductors, petrochemicals, autonomous mobile robots (AMRs), and more.Solomon will...

Read more

GlucoTrust Reviews and Complaints (2025 Consumer Report) What You Should Know Before Buying

July 7, 2025 7:50 AM

In This Article, You'll Discover:What GlucoTrust is and how it supports healthy blood sugar levelsThe science-backed ingredients used in the GlucoTrust formulaHow GlucoTrust works to improve metabolism and energy levelsThe potential health benefits of using GlucoTrust regularlyWho GlucoTrust is best suited for, and why it might helpReal customer reviews, testimonials, and feedback from usersPossible side effects and how to use the supplement...

Read more

Sleep Lean Supplement Reviews (2025 Updated) Ingredients, Results, Side Effects & Where to Buy

July 7, 2025 7:50 AM

If you've been struggling with stubborn weight that just won't seem to budge-no matter how much you diet or exercise-you're not alone. Many people find it difficult to shed extra pounds due to hidden internal factors that go beyond calorie counting. That's where Sleep Lean comes into the picture.Sleep Lean is a natural dietary supplement designed to support healthy weight loss by targeting one of the most overlooked causes of fat storage-poor...

Read more

MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada

July 7, 2025 7:00 AM

MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has officially started earlier than anticipated to evaluate MedMira's Multiplo® TP/HIV rapid test for use as a self-test in Canada.MedMira has been able to move forward with this label claim and avoid additional testing requirements (e.g., by non-health care professions) with agreement from Health Canada.The first participants have now been successfully...

Read more

ALS Community Files Citizens’ Petition asking FDA to Approve NurOwn Stem Cell Therapy

July 7, 2025 6:00 AM

On July 4, 1939, Lou Gehrig delivered his iconic "luckiest man" speech, announcing his retirement from the New York Yankees. On that day, ALS ended his Hall of Fame career. Less than two years later, ALS ended his life at just 37 years old.In the last 86 years, the lethal outcome has not changed. ALS is a cruel, paralyzing and 100% fatal disease. But today, the ALS community has hope. A coalition of ALS patients and family members has filed a...

Read more

Monthly Update June - New Share Issue, Shareholder Campaign, and Continued International Growth

July 7, 2025 5:20 AM

iZafe Group (STO:IZAFE-B) - Strong Start to the Summer - and Continued Focus on Reaching 10 MSEK in ARRJune was marked by strategic initiatives and a clear forward focus. The summer months are traditionally quieter, which is also reflected in our budget, but we remain firmly on track toward our stated goal of reaching 10 MSEK in ARR by year-end. Despite seasonal effects, the number of dispensings increased by 5% in June compared to May - a clear...

Read more

BioNxt's Sublingual Cladribine Program for MS Ready for Next Phase

July 7, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:XPHYF)(FSE:4XT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce the receipt of the active pharmaceutical ingredient (API) for its lead product candidate, BNT23001. This proprietary sublingual thin-film formulation of cladribine is being developed for the treatment of multiple sclerosis (MS).The delivery of the cladribine API enables...

Read more

DEA Cannabis Poisoned, Zero Oversight-Massachusetts Lab Scandal: A Case Study in DEA's Regulatory Collapse

July 6, 2025 5:00 AM

The Drug Enforcement Administration (DEA) exists to "prevent, detect, and investigate the diversion of controlled substances while ensuring an adequate and uninterrupted supply for legitimate medical, commercial, and scientific needs". Yet under the leadership of Deputy Administrator Thomas Prevoznik, the DEA's Diversion Control Division has catastrophically failed this mission. Instead of protecting public health, the agency has allowed...

Read more

Audifort Drops - Effective Tinnitus Relief and Hearing Support with EchoFree Tinnitus Solution

July 5, 2025 7:45 AM

Introduction: Our sense of hearing is one of the most vital and cherished aspects of our everyday lives. It allows us to communicate, experience music, connect with others, and navigate the world around us. Unfortunately, with age, environmental factors, and lifestyle choices, many people face hearing difficulties. Whether it's a gradual decline in hearing or the constant, unsettling ringing caused by tinnitus, ear health often takes a backseat...

Read more

CELFULL Unveils Celfavor NADH Microcapsules: A Breakthrough in Stability That Reshapes the Anti-Aging Industry

July 4, 2025 11:30 PM

CELFULL, a biotechnology company with over 25 years of expertise in anti-aging science, has announced a major breakthrough in longevity innovation: the global launch of Celfavor® NADH Microcapsules, a patented delivery system that resolves the century-long challenge of NADH instability. Journal papers related to NADHThis revolutionary technology-protected by seven international invention patents across the U.S., China, Japan, Canada, and South...

Read more

Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials

July 4, 2025 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into an agreement with Nucro-Technics Inc. ("Nucro-Technics"), dated July 3, 2025, pursuant to which Nucro-Technics is to conduct a broad range of preclinical studies in support of the Company's lead drug candidate. These specialized lab tests are intended to characterize the drug's behavior in...

Read more

NooCube Review - Why NooCube Is Still The No.1 Choice

July 4, 2025 9:00 AM

Explore why NooCube's science-backed formula remains the top-ranked nootropic supplement for enhancing memory, focus, and mental clarity in 2025View Official NooCube Website Here For Best PricesIn This Article, You'll Discover:The real challenges behind mental fatigue, brain fog, and reduced cognitive performanceHow NooCube's 13 key ingredients support brain function, memory, and focusWhy NooCube stands out as the top-ranked nootropic supplement...

Read more

UN-Affiliated Health Organization Appoints Dr. Anosh Ahmed to Develop COVID-19 Testing and Vaccination Standards for Northern Africa

July 4, 2025 7:00 AM

Dr. Anosh Ahmed has been officially appointed by a UN-affiliated healthcare organization to develop standardized protocols for COVID-19 testing, vaccination, and related field operations in underserved regions of Northern Africa. This initiative is part of broader international efforts aimed at strengthening health systems in areas experiencing limited infrastructure and ongoing recovery challenges.Dr. Anosh Ahmed, global health protocol...

Read more